Literature DB >> 1383975

Evidence of impaired afferent vagal function in patients with diabetes gastroparesis.

G Tougas1, R H Hunt, D Fitzpatrick, A R Upton.   

Abstract

Two patients, a 28-year-old male and a 70-year-old female, with chronic insulin dependent diabetes mellitus and evidence of autonomic neuropathy were studied using cortical evoked responses following esophageal balloon and electrical stimulation. Both patients had symptomatic gastroparesis, poor gastric emptying, and reduced gastroduodenal motility including abnormal results of scintigraphy and manometry. There was slowing of afferent vagal conduction but good evoked potential responses were recorded even though one patient could not feel electrical stimulation of either the proximal or distal esophagus. It is improbable that the gastric symptoms are due to an afferent autonomic neuropathy, but symptoms may well be related to impairment of motor vagal pathways. Nevertheless, afferent vagal pathways are involved in severe diabetes mellitus. The clinical significance of this delay in conduction velocity of afferent pathways remains to be established.

Entities:  

Mesh:

Year:  1992        PMID: 1383975     DOI: 10.1111/j.1540-8159.1992.tb02939.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  13 in total

1.  Glucose sensing by gut endocrine cells and activation of the vagal afferent pathway is impaired in a rodent model of type 2 diabetes mellitus.

Authors:  Jennifer Lee; Bethany P Cummings; Elizabeth Martin; James W Sharp; James L Graham; Kimber L Stanhope; Peter J Havel; Helen E Raybould
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-12-07       Impact factor: 3.619

2.  Diabetic gastropathy and interstitial cells of Cajal: a clue for bringing understanding out of chaos?

Authors:  Ryuichi Iwakiri; Kazuma Fujimoto
Journal:  J Gastroenterol       Date:  2006-11       Impact factor: 7.527

3.  Cortical evoked responses following esophageal balloon distension and electrical stimulation in healthy volunteers.

Authors:  S Hollerbach; P Hudoba; D Fitzpatrick; R Hunt; A R Upton; G Tougas
Journal:  Dig Dis Sci       Date:  1998-11       Impact factor: 3.199

Review 4.  Inhibitory neurotransmission regulates vagal efferent activity and gastric motility.

Authors:  Caitlin A McMenamin; R Alberto Travagli; Kirsteen N Browning
Journal:  Exp Biol Med (Maywood)       Date:  2016-06

Review 5.  Gastrointestinal motility and glycemic control in diabetes: the chicken and the egg revisited?

Authors:  Christopher K Rayner; Michael Horowitz
Journal:  J Clin Invest       Date:  2006-02       Impact factor: 14.808

6.  GDNF rescues hyperglycemia-induced diabetic enteric neuropathy through activation of the PI3K/Akt pathway.

Authors:  Mallappa Anitha; Chetan Gondha; Roy Sutliff; Alexander Parsadanian; Simon Mwangi; Shanthi V Sitaraman; Shanthi Srinivasan
Journal:  J Clin Invest       Date:  2006-02       Impact factor: 14.808

7.  Altered calcium signaling in colonic smooth muscle of type 1 diabetic mice.

Authors:  Ketrija Touw; Saikat Chakraborty; Wenwu Zhang; Alexander G Obukhov; Johnathan D Tune; Susan J Gunst; B Paul Herring
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-10-06       Impact factor: 4.052

8.  ER stress and ER stress-induced apoptosis are activated in gastric SMCs in diabetic rats.

Authors:  Xia Chen; Xiang-Sheng Fu; Chang-Ping Li; Hong-Xian Zhao
Journal:  World J Gastroenterol       Date:  2014-07-07       Impact factor: 5.742

Review 9.  Diabetes and the enteric nervous system.

Authors:  B Chandrasekharan; S Srinivasan
Journal:  Neurogastroenterol Motil       Date:  2007-10-17       Impact factor: 3.598

10.  Central processing of gut pain in diabetic patients with gastrointestinal symptoms.

Authors:  Jens Brøndum Frøkjaer; Eirik Søfteland; Carina Graversen; Georg Dimcevski; Line Lindhardt Egsgaard; Lars Arendt-Nielsen; Asbjørn Mohr Drewes
Journal:  Diabetes Care       Date:  2009-04-14       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.